Buscar
Surrozen Inc
SRZNAñadir a la lista de seguimiento
33.680USD
+17.520+108.42%
Cierre 09-24 16:00（ET）
391.02MCap. mercado
PérdidaP/E TTM
Fuera de horario 17:00 (ET)34.000USD+0.220+0.65%
Fuera de horario 17:00 (ET)Acerca de Surrozen Inc Compañía
Surrozen, Inc. is a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway. The Company is developing tissue-specific antibodies designed to engage the body’s existing biological repair mechanisms with a focus in ophthalmology. Its product candidates include SZN-8141 for Retinal Diseases, SZN-8143 for Retinal Diseases, SZN-113 for Fuchs’ Endothelial Corneal Dystrophy and Geographic Atrophy, and SZN-413 for Retinal Diseases. SZN-8141 combines Frizzled 4 (Fzd4) agonism and Vascular Endothelial Growth Factor (VEGF) antagonism which has the potential to provide benefits over treatment with single agents for Diabetic Macular Edema (DME) and neovascular Age Related Macular Degeneration (wet AMD). SZN-8143 combines Fzd4 agonism, VEGF antagonism, and interleukin-6 (IL-6) antagonism which may have benefits over single agents for treatment of DME/wet AMD/uveitic macular edema. SZN-413 is a bi-specific antibody, designed using its SWAP technology.
Perfil de Surrozen Inc
Símbolo de cotizaciónSRZN
Nombre de la empresaSurrozen Inc
Fecha de salida a bolsaNov 23, 2020
Director ejecutivoParker (Craig C)
Número de empleados40
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 23
Dirección171 Oyster Point Blvd
CiudadSOUTH SAN FRANCISCO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal94080
Teléfono16504752820
Sitio Webhttps://www.surrozen.com
Símbolo de cotizaciónSRZN
Fecha de salida a bolsaNov 23, 2020
Director ejecutivoParker (Craig C)
Ejecutivos de Surrozen Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Yang Li, Ph.D.
Dr. Yang Li, Ph.D.
Executive Vice President - Research
Executive Vice President - Research
19.58K
+8.51%
Dr. Yang Li, Ph.D.
Dr. Yang Li, Ph.D.
Executive Vice President - Research
Executive Vice President - Research
19.58K
+8.51%
Mr. Charles O. Williams
Mr. Charles O. Williams
Chief Operating Officer, Corporate Secretary
Chief Operating Officer, Corporate Secretary
18.24K
+9.14%
Mr. Charles O. Williams
Mr. Charles O. Williams
Chief Operating Officer, Corporate Secretary
Chief Operating Officer, Corporate Secretary
18.24K
+9.14%
Dr. Anna Berkenblit, M.D.
Dr. Anna Berkenblit, M.D.
Independent Director
Independent Director
2.34K
--
Dr. Shao-Lee Lin, M.D., Ph.D.
Dr. Shao-Lee Lin, M.D., Ph.D.
Independent Director
Independent Director
2.34K
--
Dr. Mace Rothenberg, M.D.
Dr. Mace Rothenberg, M.D.
Independent Director
Independent Director
2.34K
--
Mr. Christopher Y. Chai
Mr. Christopher Y. Chai
Independent Director
Independent Director
2.34K
--
Dr. Mary Haak-Frendscho, Ph.D.
Dr. Mary Haak-Frendscho, Ph.D.
Independent Director
Independent Director
2.34K
--
Dr. Anna Berkenblit, M.D.
Dr. Anna Berkenblit, M.D.
Independent Director
Independent Director
2.34K
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Yang Li, Ph.D.
Dr. Yang Li, Ph.D.
Executive Vice President - Research
Executive Vice President - Research
19.58K
+8.51%
Dr. Yang Li, Ph.D.
Dr. Yang Li, Ph.D.
Executive Vice President - Research
Executive Vice President - Research
19.58K
+8.51%
Mr. Charles O. Williams
Mr. Charles O. Williams
Chief Operating Officer, Corporate Secretary
Chief Operating Officer, Corporate Secretary
18.24K
+9.14%
Mr. Charles O. Williams
Mr. Charles O. Williams
Chief Operating Officer, Corporate Secretary
Chief Operating Officer, Corporate Secretary
18.24K
+9.14%
Dr. Anna Berkenblit, M.D.
Dr. Anna Berkenblit, M.D.
Independent Director
Independent Director
2.34K
--
Dr. Shao-Lee Lin, M.D., Ph.D.
Dr. Shao-Lee Lin, M.D., Ph.D.
Independent Director
Independent Director
2.34K
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Surrozen Inc?
Los cinco principales accionistas de Surrozen Inc son: Dr. Yang Li, Ph.D.
¿Cuántas instituciones poseen acciones de Surrozen Inc (SRZN)?
A fecha de 2026Q1, 78 instituciones poseen acciones de Surrozen Inc, con un valor de mercado combinado de aproximadamente 10.96M, lo que representa el 94.38% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 2007039.00.